Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis
- 1 November 2007
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (11) , 1497-1502
- https://doi.org/10.1136/ard.2006.067603
Abstract
Background: Certain sequences present in the hypervariable region of human leucocyte antigen (HLA)-DRB1 known as the shared epitope (SE) are hypothesised to increase the risk of rheumatoid arthritis (RA), whereas alleles encoding aspartic acid at position 70 (D70 alleles) may have a protective effect. Methods: Patient HLA-DRB1 serotypes were assessed and the genotypes encoding the SE motif or the putatively protective D70 motif identified in a large RA cohort. Logistic regression was used to analyse associations of genotype with presence of disease, comorbidities and disease severity, and association between genotype and change in disease activity over time. Results: The 689 patients enrolled had a mean (SD) age of 57.9 (13.7) years and mean (SD) disease duration of 15.3 (12.7) years. In a comparison with 482 ethnicity matched population-based controls, the D70 sequence exerted a strong protective effect (OR = 0.52, pConclusion: The D70 allele has a significant protective effect that is mitigated but still significant when the risk effect of the SE at the same locus is taken into account. The presence of the SE on DR4 is associated with greater RA susceptibility and certain disease-activity measures.Keywords
This publication has 42 references indexed in Scilit:
- Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposureRheumatology, 2005
- HLA-DRB1 alleles encoding the “shared epitope” are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the β-chain are protective in Mexican mestizosHuman Immunology, 2004
- An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trialArthritis & Rheumatism, 2003
- HLA–DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment biasArthritis & Rheumatism, 2002
- Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA allelesGenes & Immunity, 2002
- MAJOR HISTOCOMPATIBILITY COMPLEX VARIANTS AND ARTICULAR DISEASE SEVERITY IN RHEUMATOID ARTHRITISRheumatology, 1993
- Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.Annals of the Rheumatic Diseases, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987
- Association of HLA‐DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritisArthritis & Rheumatism, 1984